Items where Author is "Johnson, TS"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 15.

Journal article

FURINI, G., SCHROEDER, N., HUANG, L., BOOCOCK, D., SCARPELLINI, A., COVENEY, C., TONOLI, E., RAMASWAMY, R., BALL, G., VERDERIO, C., JOHNSON, T.S. and VERDERIO, E.A.M., 2018. Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction. Journal of the American Society of Nephrology, 29 (3), pp. 880-905. ISSN 1046-6673

BURHAN, I., FURINI, G., LORTAT-JACOB, H., ATOBATELE, A.G., SCARPELLINI, A., SCHROEDER, N., ATKINSON, J., MAAMRA, M., NUTTER, F.H., WATSON, P., VINCIGUERRA, M., JOHNSON, T.S. and VERDERIO, E.A.M., 2016. Interplay between transglutaminases and heparan sulphate in progressive renal scarring. Scientific Reports, 6, p. 31343. ISSN 2045-2322

SCARPELLINI, A., HUANG, L., BURHAN, I., SCHROEDER, N., FUNCK, M., JOHNSON, T.S. and VERDERIO, E.A.M., 2014. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis. Journal of the American Society of Nephrology, 25 (5), pp. 1013-1027. ISSN 1046-6673

HUANG, L., SCARPELLINI, A., FUNCK, M., VERDERIO, E.A.M. and JOHNSON, T.S., 2013. Development of an effective Chronic Kidney Disease (CKD) model in C57BL/6 mice with histology relevant to human disease [forthcoming]. Nephron Extra. ISSN 1664-5529

LORTAT-JACOB, H., BURHAN, I., SCARPELLINI, A., THOMAS, A., IMBERTY, A., VIVÈS, R.R., JOHNSON, T.S., GUTIERREZ, A. and VERDERIO, E.A.M., 2012. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix. Journal of Biological Chemistry, 287 (22), pp. 18005-18017. ISSN 0021-9258

CHOU, C.Y., STREETS, A.J., WATSON, P.F., HUANG, L., VERDERIO, E. and JOHNSON, T.S., 2011. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal {beta}-sandwich domain. Journal of Biological Chemistry, 286, pp. 27825-27835.

JONES, R.A., KOTSAKIS, P., JOHNSON, T.S., CHAU, D., VERDERIO, E., ALI, S. and GRIFFIN, M., 2005. Extracellular matrix changes induced by transglutaminase 2 block angiogenesis and tumor growth. FEBS Journal, 272, p. 411. ISSN 1742-464X

EL, N., BO-ZENAH, H., SKILL, N.J., BEX, S., WILD, G., GRIFFIN, M. and JOHNSON, T.S., 2004. Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase. Nephron Clinical Practice, 97 (3), pp. 108-117. ISSN 1660-2110

SKILL, N.J., JOHNSON, T.S., COUTTS, I.G.C., SAINT, R.E., FISHER, M., HUANG, L.H., EL, N., COLLIGHAN, R.J. and GRIFFIN, M., 2004. Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells. Journal of Biological Chemistry, 279 (46), pp. 47754-47762. ISSN 0021-9258

JOHNSON, T.S., BO-ZENAH, H., SKILL, J.N., BEX, S., WILD, G., BROWN, C.B., GRIFFIN, M. and EL, N., 2004. Tissue transglutaminase: A mediator and predictor of chronic allograft nephropathy? Transplantation, 77 (11), pp. 1667-1675. ISSN 0041-1337

JOHNSON, T.S., EL-KORAIE, A.F., SKILL, N.J., BADDOUR, N.M., EL, N., NJLOMA, M., ADAM, A.G. and GRIFFIN, M., 2003. Tissue transglutaminase and the progression of human renal scarring. Journal of the American Society of Nephrology, 14 (8), pp. 2052-2062. ISSN 1046-6673

SKILL, N.J., GRIFFIN, M., EL, N., SANAI, T., HAYLOR, J.L., FISHER, M., JAMIE, M.F., MOULD, N.N. and JOHNSON, T.S., 2001. Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications. Laboratory Investigation, 81 (5), pp. 705-716. ISSN 0023-6837

JOHNSON, T.S., KNIGHT, C.R.L., ELALAOUI, S., MIAN, S., REES, R.C., GENTILE, V., DAVIES, P.J.A. and GRIFFIN, M., 1994. Transfection of Tissue Transglutaminase Into A Highly Malignant Hamster Fibrosarcoma Leads to A Reduced Incidence of Primary Tumor-Growth. Oncogene, 9 (10), pp. 2935-2942. ISSN 0950-9232

Chapter in book

VERDERIO, E.A.M., FURINI, G., BURHAN, I.W. and JOHNSON, T.S., 2015. Transglutaminases: expression in kidney and relation to kidney fibrosis. In: K. HITOMI, S. KOJIMA and L. FESUS, eds., Transglutaminases: multiple functional modifiers and targets for new drug discovery. Tokyo: Springer, pp. 229-262. ISBN 9784431558231

Thesis

JOHNSON, T.S., 1995. Transglutaminase apoptosis and tumour progression. PhD, Nottingham Trent University.

This list was generated on Thu Oct 21 00:02:07 2021 UTC.